Key result
White coat hypertension was associated with a significantly higher prevalence of dyslipidemia (33.33% vs 12.96%) and other metabolic disorders compared to sustained normotension.
Why the study?
Is white coat hypertension associated with a higher prevalence of cardiometabolic risk factors compared to sustained normotension?
Cross-Sectional (n=169)
No
Is white coat hypertension associated with a higher prevalence of cardiometabolic risk factors compared to sustained normotension?
Absolute Event Rate: 33.33% vs 12.96%
p-value: p=<0.001
White coat hypertension is associated with a higher burden of cardiometabolic comorbidities compared to normotension, suggesting it is a high-risk state requiring active management of associated risk factors.
No takes yet. Share an insight, caveat, or question.
May prompt cardiometabolic screening in white coat hypertension; leaves open causal and prognostic implications.
Helvacı et al. (2007) conducted a cross-sectional in White coat hypertension (n=169). White coat hypertension vs. Sustained normotension was evaluated on Prevalence of dyslipidemia (p=<0.001). White coat hypertension was associated with a significantly higher prevalence of dyslipidemia (33.33% vs 12.96%) and other metabolic disorders compared to sustained normotension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: